Compare YDES & NATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | YDES | NATH |
|---|---|---|
| Founded | 2013 | 1916 |
| Country | Taiwan | United States |
| Employees | N/A | N/A |
| Industry | | Restaurants |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 476.8M | 405.6M |
| IPO Year | 2024 | 1996 |
| Metric | YDES | NATH |
|---|---|---|
| Price | $5.85 | $101.96 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 380.9K | 31.3K |
| Earning Date | 08-31-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 1.96% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.14 |
| Revenue | N/A | ★ $104,201,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $47.64 |
| Revenue Growth | N/A | ★ 7.81 |
| 52 Week Low | $1.70 | $88.67 |
| 52 Week High | $18.57 | $110.92 |
| Indicator | YDES | NATH |
|---|---|---|
| Relative Strength Index (RSI) | 51.40 | 63.66 |
| Support Level | $4.97 | $100.68 |
| Resistance Level | $8.89 | $102.00 |
| Average True Range (ATR) | 1.01 | 0.20 |
| MACD | -0.18 | -0.06 |
| Stochastic Oscillator | 20.43 | 98.53 |
YD Bio Ltd is a biotechnology company focused on regulated diagnostics, life science clinical services and healthcare product commercialization. Its operations include DNA methylation-based oncology testing programs in the United States under an LDT framework with CLIA-certified and CAP-accredited laboratory partners. The Company also provides life science distribution and clinical trial supply chain services, including procurement, logistics coordination and compliance-focused support for clinical development programs. It maintains ocular health product commercialization operations in the United States and consumer healthcare distribution activities in Asia. The Company operates in the United States and Taiwan, with Taiwan generating maximum revenue.
Nathan's Famous Inc is a branded licensor, wholesaler and retailer of products marketed under its brand. Its products are currently marketed for sale in thousands of locations, including supermarkets, mass merchandisers and club stores, selected foodservice locations and its company-owned and franchised restaurants throughout the United States and in twenty foreign countries. It considers itself to be in the foodservice industry. It has three segments Branded Product Program, Product Licensing, Restaurant Operations, of which majority of revenue is from Branded Product Program which derives from the sale of hot dog products either directly to foodservice operators or to various foodservice distributors. It generates majority of revenue from United States.